Study With a Topical Gel to Treat Common Warts in Adults

A Two-Stage, Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 5 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Adults

The primary purpose of this study is to evaluate the effectiveness in adults of 2 different strengths of resiquimod gel applied to common wart(s) five times a week for up to 12 weeks.

A second purpose is to evaluate the safety of the drug.

Inclusion Criteria:

• Diagnosis of common warts
• Two forms of birth control

Exclusion Criteria:

• Pregnant or breast feeding
• Other types of warts, ie. plantar
• Currently participating in another clinical study
• Chronic viral hepatitis B or C